The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Requirement for Arf6 in breast cancer invasive activities
Open accessAbstract
In most human breast cancer cell lines, there is a direct correlation between their in vivo invasive phenotypes and in vitro invasion activities. Here, we found that ADP-ribosylation factor 6 (Arf6) is localized at the invadopodia of the cultured breast cancer cells MDA-MB-231, and its suppression by a small-interfering RNA duplex effectively blocks the invasive activities of the cells, such as invadopodia formation, localized matrix degradation and Matrigel transmigration but not the cell-adhesion activity. We also found that the GTP hydrolysis-defective mutant Arf6(Q67L) and the GTP-binding defective mutant Arf6(T27N) both blocked these invasive activities but not cell adhesion, suggesting the necessity of continued activation and cycling of the Arf6 GTPase cycle in invasion. Among the different human breast cancer cell lines that we examined, cell lines with high invasive activities expressed higher amounts of Arf6 protein than those in weakly invasive and noninvasive cell lines, although no notable correlation was found between Arf6 mRNA expression levels and invasive activities. Moreover, Matrigel-transmigration activity of all of these invasive cells was blocked effectively by an Arf6 small-interfering RNA duplex. Hence, Arf6 appears to be an integral component of breast cancer invasive activities, and we propose that Arf6 and the intracellular machinery regulating Arf6 during invasion should be considered as therapeutic targets for the prevention of breast cancer invasion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells
Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., & Tuschl, T. (2001) · Nature · doi:10.1038/35078107 · Cited by 9,456
Tumour-cell invasion and migration: diversity and escape mechanisms
Friedl, P., & Wolf, K. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1075 · Cited by 3,222
Mechanisms of phagocytosis in macrophages
Aderem, A., & Underhill, D. M. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.593 · Cited by 2,854
Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations
Coussens, L. M., Fingleton, B., & Matrisian, L. M. (2002) · Science · doi:10.1126/science.1067100 · Cited by 2,761
A multigenic program mediating breast cancer metastasis to bone
Kang, Y., Siegel, P. M., Shu, W., Drobnjak, M., Kakonen, S. M., Cordón-Cardo, C., Guise, T. A., & Massagué, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00132-6 · Cited by 2,597
Morgenstern, J. P., & Land, H. (1990) · Nucleic Acids Research · doi:10.1093/nar/18.12.3587 · Cited by 2,101
Strategies for MMP inhibition in cancer: innovations for the post-trial era
Overall, C. M., & López-Otín, C. (2002) · Nature Reviews Cancer · doi:10.1038/nrc884 · Cited by 1,349
Molecular cloning of cDNA encoding human interleukin-2 receptor
Nikaido, T., Shimizu, A., Ishida, N., Sabe, H., Teshigawara, K., Maeda, M., Uchiyama, T., Yodoi, J., & Honjo, T. (1984) · Nature · doi:10.1038/311631a0 · Cited by 565
Self-citationCritical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment
Zucker, S., Cao, J., & Chen, W.-T. (2000) · Oncogene · doi:10.1038/sj.onc.1204097 · Cited by 550
Thompson, E. W., Paik, S., Brünner, N., Sommers, C. L., Zugmaier, G., Clarke, R., Shima, T. B., Torri, J., Donahue, S., Lippman, M. E., et al. (1992) · Journal of Cellular Physiology · doi:10.1002/jcp.1041500314 · Cited by 523
ADP-Ribosylation Factor 6 Regulates a Novel Plasma Membrane Recycling Pathway
Radhakrishna, H., & Donaldson, J. G. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.139.1.49 · Cited by 508
Multiple Roles for Arf6: Sorting, Structuring, and Signaling at the Plasma Membrane
Donaldson, J. G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.r300026200 · Cited by 473
A Regulatory Role for ARF6 in Receptor-Mediated Endocytosis
D'Souza-Schorey, C., Li, G., Colombo, M. I., & Stahl, P. D. (1995) · Science · doi:10.1126/science.7855600 · Cited by 454
Chardin, P., & McCormick, F. (1999) · Cell · doi:10.1016/s0092-8674(00)80724-2 · Cited by 407
Bowden, E. T., Barth, M., Thomas, D., Glazer, R. I., & Mueller, S. C. (1999) · Oncogene · doi:10.1038/sj.onc.1202827 · Cited by 356
Moss, J., & Vaughan, M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.34.21431 · Cited by 344
Yoneda, T., Sasaki, A., Dunstan, C., Williams, P. J., Bauss, F., De Clerck, Y. A., & Mundy, G. R. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119435 · Cited by 247
A Requirement for ARF6 in Fcγ Receptor-mediated Phagocytosis in Macrophages
Zhang, Q., Cox, D., Tseng, C.-C., Donaldson, J. G., & Greenberg, S. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.19977 · Cited by 208
Niedergang, F., Colucci-Guyon, E., Dubois, T., Raposo, G., & Chavrier, P. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200210069 · Cited by 198
Coopman, P. J., Do, M. T., Thompson, E. W., & Mueller, S. C. (1998) · PubMed · Cited by 135
Kondo, A., Hashimoto, S., Yano, H., Nagayama, K., Mazaki, Y., & Sabe, H. (2000) · Molecular Biology of the Cell · doi:10.1091/mbc.11.4.1315 · Cited by 127
Self-citationCytohesins and centaurins: mediators of PI 3-kinase-regulated Arf signaling
Jackson, T., Kearns, B. G., & Theibert, A. B. (2000) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)01644-3 · Cited by 126
Chapter 29 Invadopodia: Unique methods for measurement of extracellular matrix degradation in vitro
Bowden, E. T., Coopman, P. J., & Mueller, S. C. (2001) · Methods in cell biology · doi:10.1016/s0091-679x(01)63033-4 · Cited by 116
Kang, T., Nagase, H., & Pei, D. (2002) · PubMed · Cited by 114
Building a secretory apparatus: role of ARF1/COPI in Golgi biogenesis and maintenance
Lippincott‐Schwartz, J., Cole, N. B., & Donaldson, J. G. (1998) · Histochemistry and Cell Biology · doi:10.1007/s004180050247 · Cited by 100
Coopman, P. J. P., Thomas, D. M., Gehlsen, K. R., & Mueller, S. C. (1996) · Molecular Biology of the Cell · doi:10.1091/mbc.7.11.1789 · Cited by 91
Uchida, H., Kondo, A., Yoshimura, Y., Mazaki, Y., & Sabe, H. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.8.955 · Cited by 59
Self-citationYang, C. Z., Heimberg, H., D’Souza‐Schorey, C., Mueckler, M. M., & Stahl, P. D. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.7.4006 · Cited by 56
Kahn, R. (2003) · Springer eBooks · doi:10.1007/1-4020-2593-9 · Cited by 46
Ho, W., Exton, J. H., & Williger, B.-T. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00098-x · Cited by 16
Cited by
ARF proteins: roles in membrane traffic and beyond
D'Souza-Schorey, C., & Chavrier, P. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1910 · Cited by 1,378
ARF6-Regulated Shedding of Tumor Cell-Derived Plasma Membrane Microvesicles
Muralidharan-Chari, V., Clancy, J., Plou, C., Romao, M., Chavrier, P., Raposo, G., & D'Souza-Schorey, C. (2009) · Current Biology · doi:10.1016/j.cub.2009.09.059 · Cited by 912
Ras superfamily GEFs and GAPs: validated and tractable targets for cancer therapy?
Vigil, D., Cherfils, J., Rossman, K. L., & Der, C. J. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2960 · Cited by 819
Yamaguchi, H., Wyckoff, J., & Condeelis, J. (2005) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2005.08.002 · Cited by 761
The matrix corroded: podosomes and invadopodia in extracellular matrix degradation
Linder, S. (2007) · Trends in Cell Biology · doi:10.1016/j.tcb.2007.01.002 · Cited by 640
Metadata
- Authors
- Hashimoto, S., Onodera, Y., Hashimoto, A., Tanaka, M., Hamaguchi, M., Yamada, A., & Sabe, H.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2004-04-15
- Volume
- 101
- Issue
- 17
- Pages
- 6647-6652
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2056546350
- Cited by
- 270
- References
- 31
- FWCI
- 5.46
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.